| 1 |
Brugos B, Zeher M. Biomarkers in lupus nephritis[J]. Orv Hetil,2010,151(29):1171-1176.
|
| 2 |
Fiehn C. Early diagnosis and treatment in lupus nephritis: how we can influence the risk for terminal renal failure[J]. J Rheumatol,2006,33(8):1464-1466.
|
| 3 |
Kjeldsen L, Johnsen A H, Sengelov H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase[J]. J Biol Chem, 1993,268(14): 10425-10432.
|
| 4 |
Yan L, Borregaard N, Kjeldsen L, et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin(NGAL). Modulation of MMP-9 activity by NGAL[J]. J Biol Chem,2001,276(40):37258-37265.
|
| 5 |
Kulkarni O, Anders HJ. Chemokines in lupus nephritis[J]. Front Biosci, 2008,13:3312-3320.
|
| 6 |
Goetz DH, Holmes MA, Borregaard N, et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophoremediated iron acquisition[J]. Mol Cell, 2002,10 (5):1033-1043.
|
| 7 |
Goetz DH, Willie ST, Armen RS, et al. Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin[J].Biochemistry, 2000,39(8):1935-1941.
|
| 8 |
Berger T, Togawa A, Duncan GS, et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury[J]. Proc Natl Acad Sci U S A,2006,103(6):1834-1839.
|
| 9 |
Roudkenar MH, Halabian R, Ghasemipour Z, et al. Neutrophil gelatinase-associated lipocalin acts as a protective factor against H(2)O(2) toxicity[J]. Arch Med Res, 2008,39(6):560-566.
|
| 10 |
Gwira JA, Wei F, Ishibe S, et al. Expression of neutrophil gelatinaseassociated lipocalin regulates epithelial morphogenesis in vitro[J]. J Biol Chem, 2005,280(9):7875-7882.
|
| 11 |
Ding H, He Y, Li K, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy[J]. Clin Immunol, 2007,123(2):227-234.
|
| 12 |
Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinaseassociated lipocalin as a novel early urinary biomarker for ischemic renal injury[J]. J Am Soc Nephrol, 2003,14(10): 2534-2543.
|
| 13 |
Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalinsiderophore-iron complex rescues the kidney from ischemiareperfusion injury[J]. J Clin Invest, 2005,115(3): 610-621.
|
| 14 |
Ka SM, Rifai A, Chen JH, et al. Glomerular crescent-related biomarkers in a murine model of chronic graft versus host disease[J].Nephrol Dial Transplant, 2006,21(2):288-298.
|
| 15 |
Viau A, El Karoui K, Laouari D, et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans[J]. Clin Invest,2010,120(11):4065-4076.
|
| 16 |
An S, Zang X, Yuan W, et al. Neutrophil gelatinase-associated lipocalin(NGAL) may play a protective role against rats ischemia/reperfusion renal injury via inhibiting tubular epithelial cell apoptosis[J]. Ren Fail,2013,35(1):143-149.
|
| 17 |
Alcaraz AJ, Gil-Ruiz MA, Castillo A, et al. Postoperative neutrophil gelatinase-associated lipocalin predicts acute kidney injury after pediatric cardiac surgery[J]. Pediatr Crit Care Med, 2014,15(2):121-130.
|
| 18 |
Cai L, Borowiec J, Xu S, et al. Assays of urine levels of HNL/NGAL in patients undergoing cardiac surgery and the impact of antibody configuration on their clinical performances[J]. Clin Chim Acta,2009,403(1-2):121-125.
|
| 19 |
Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery[J]. Lancet, 2005,365(9466):1231-1238.
|
| 20 |
Giasson J, Li GH, Chen Y. Neutrophil gelatinase-associated lipocalin(NGAL) as a new biomarker for non--acute kidney injury (AKI)diseases[J]. Inflamm Allergy Drug Targets, 2011,10(4):272-282.
|
| 21 |
Elewa EA, El TM, Fathy SE, et al. Predictive role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis[J]. Lupus,2015,24(2):138-146.
|
| 22 |
Woo KS, Choi JL, Kim BR, et al. Urinary neutrophil gelatinaseassociated lipocalin levels in comparison with glomerular filtration rate for evaluation of renal function in patients with diabetic chronic kidney disease[J]. Diabetes Metab J, 2012,36(4):307-313.
|
| 23 |
Mitsnefes MM, Kathman TS, Mishra J, et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease[J]. Pediatr Nephrol, 2007,22(1):101-108.
|
| 24 |
Bhavsar NA, Kottgen A, Coresh J, et al. Neutrophil gelatinaseassociated lipocalin (NGAL) and kidney injury molecule 1(KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study[J]. Am J Kidney Dis, 2012,60(2):233-240.
|
| 25 |
Fufaa GD, Weil EJ, Nelson RG, et al. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus[J].Diabetologia, 2015,58(1):188-198.
|
| 26 |
Suzuki M, Wiers KM, Klein-Gitelman MS, et al. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis[J]. Pediatr Nephrol, 2008,23 (3):403-412.
|
| 27 |
Hammad A, Mosaad Y, Elhanbly S, et al. Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children[J]. Lupus, 2013,22(5):486-491.
|
| 28 |
Brunner HI, Mueller M, Rutherford C, et al. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus[J]. Arthritis Rheum,2006,54(8):2577-2584.
|
| 29 |
Suzuki M, Wiers KM, Klein-Gitelman MS, et al. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis[J]. Pediatr Nephrol, 2008, 23(3):403-412.
|
| 30 |
Yang CC, Hsieh SC, Li KJ, et al. Urinary neutrophil gelatinaseassociated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus[J]. J Biomed Biotechnol,2012,2012:759313.
|
| 31 |
Pitashny M, Schwartz N, Qing X, et al. Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis[J].Arthritis Rheum, 2007,56(6):1894-1903.
|
| 32 |
Susianti H, Iriane VM, Dharmanata S, et al. Analysis of urinary TGFbeta1, MCP-1, NGAL, and IL-17 as biomarkers for lupus nephritis[J].Pathophysiology, 2015,22(1):65-71.
|
| 33 |
Hinze CH, Suzuki M, Klein-Gitelman M, et al. Neutrophil gelatinaseassociated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity[J].Arthritis Rheum, 2009,60(9):2772-2781.
|
| 34 |
Paragas N, Qiu A, Zhang Q, et al. The Ngal reporter mouse detects the response of the kidney to injury in real time[J]. Nat Med,2011,17(2):216-222.
|
| 35 |
Cai L, Rubin J, Han W, et al. The origin of multiple molecular forms in urine of HNL/NGAL[J]. Clin J Am Soc Nephrol, 2010,5(12):2229-2235.
|
| 36 |
Martensson J, Xu S, Bell M, et al. Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils[J]. Clin Chim Acta, 2012, 413(19-20):1661-1667.
|